|
Originally published In Press as doi:10.1074/jbc.M406123200 on July 23, 2004
J. Biol. Chem., Vol. 279, Issue 40, 41487-41494, October 1, 2004
Interaction of Telomestatin with the Telomeric Single-strand Overhang*
Dennis Gomez ,
Rajaa Paterski ,
Thibault Lemarteleur ,
Kazuo Shin-ya ,
Jean-Louis Mergny¶, and
Jean-François Riou ||
From the
Laboratoire d'Onco-Pharmacologie, JE 2428, UFR de Pharmacie, Université de Reims Champagne Ardenne, 51 rue Cognacq-Jay, 51096 Reims, France, the Institute of Molecular and Cellular Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0032, Japan, and the ¶Laboratoire de Biophysique, Muséum National d'Histoire Naturelle USM 503, INSERM Unité 565, CNRS UMR 5153, 43 rue Cuvier, 75005 Paris, France
The extremities of chromosomes end in a G-rich single-stranded overhang that has been implicated in the onset of the replicative senescence. The repeated sequence forming a G-overhang is able to adopt a peculiar four-stranded DNA structure in vitro called a G-quadruplex, which is a poor substrate for telomerase. Small molecule ligands that selectively stabilize the telomeric G-quadruplex induce telomere shortening and a delayed growth arrest. Here we show that the G-quadruplex ligand telomestatin has a dramatic effect on the conformation of intracellular G-overhangs. Competition experiments indicate that telomestatin strongly binds in vitro and in vivo to the telomeric overhang and impairs its single-stranded conformation. Long-term treatment of cells with telomestatin greatly reduces the G-overhang size, as evidenced by specific hybridization or telomeric oligonucleotide ligation assay experiments, with a concomitant delayed loss of cell viability. In vivo protection experiments using dimethyl sulfate also indicate that telomestatin treatment alters the dimethyl sulfate effect on G-overhangs, a result compatible with the formation of a local quadruplex structure at telomeric overhang. Altogether these experiments strongly support the hypothesis that the telomeric G-overhang is an intracellular target for the action of telomestatin.
Received for publication, June 2, 2004
, and in revised form, July 21, 2004.
* This work was supported by Association pour la Recherche contre le Cancer Grants 4321 and 3365 (to J.-L. M.) and 4691 (to J.-F. R.) and an Action Concertée Incitative "Médicament et Cibles thérapeutiques" from the Ministère de la Recherche et de la Technologie (to J.-L. M. and J.-F. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
|| To whom correspondence should be addressed: JE 2428 Onco-Pharmacologie, UFR de Pharmacie, 51 rue Cognacq-Jay, 51096 Reims, France. E-mail: jf.riou{at}univ-reims.fr.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. M. Pedroso, W. Hayward, and T. M. Fletcher
The effect of the TRF2 N-terminal and TRFH regions on telomeric G-quadruplex structures
Nucleic Acids Res.,
April 1, 2009;
37(5):
1541 - 1554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Sun and L. H Hurley
Telomestatin as a Structural Probe for Targeting G-quadruplexes in Telomeric and Promoter Regions
Am. Assoc. Cancer Res. Educ. Book,
April 12, 2008;
2008(1):
315 - 318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Brassart, D. Gomez, A. D. Cian, R. Paterski, A. Montagnac, K.-H. Qui, N. Temime-Smaali, C. Trentesaux, J.-L. Mergny, F. Gueritte, et al.
A New Steroid Derivative Stabilizes G-Quadruplexes and Induces Telomere Uncapping in Human Tumor Cells
Mol. Pharmacol.,
September 1, 2007;
72(3):
631 - 640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Barbieri, A. R. Srinivasan, S. G. Rzuczek, J. E. Rice, E. J. LaVoie, and D. S. Pilch
Defining the mode, energetics and specificity with which a macrocyclic hexaoxazole binds to human telomeric G-quadruplex DNA
Nucleic Acids Res.,
May 11, 2007;
35(10):
3272 - 3286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Gomez, T. Wenner, B. Brassart, C. Douarre, M.-F. O'Donohue, V. El Khoury, K. Shin-ya, H. Morjani, C. Trentesaux, and J.-F. Riou
Telomestatin-induced Telomere Uncapping Is Modulated by POT1 through G-overhang Extension in HT1080 Human Tumor Cells
J. Biol. Chem.,
December 15, 2006;
281(50):
38721 - 38729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Gomez, M.-F. O'Donohue, T. Wenner, C. Douarre, J. Macadre, P. Koebel, M.-J. Giraud-Panis, H. Kaplan, A. Kolkes, K. Shin-ya, et al.
The G-quadruplex Ligand Telomestatin Inhibits POT1 Binding to Telomeric Sequences In vitro and Induces GFP-POT1 Dissociation from Telomeres in Human Cells.
Cancer Res.,
July 15, 2006;
66(14):
6908 - 6912.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Zaug, E. R. Podell, and T. R. Cech
Human POT1 disrupts telomeric G-quadruplexes allowing telomerase extension in vitro
PNAS,
August 2, 2005;
102(31):
10864 - 10869.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Granotier, G. Pennarun, L. Riou, F. Hoffschir, L. R. Gauthier, A. De Cian, D. Gomez, E. Mandine, J.-F. Riou, J.-L. Mergny, et al.
Preferential binding of a G-quadruplex ligand to human chromosome ends
Nucleic Acids Res.,
July 28, 2005;
33(13):
4182 - 4190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Douarre, D. Gomez, H. Morjani, J.-M. Zahm, M.-F. O'Donohue, L. Eddabra, P. Mailliet, J.-F. Riou, and C. Trentesaux
Overexpression of Bcl-2 is associated with apoptotic resistance to the G-quadruplex ligand 12459 but is not sufficient to confer resistance to long-term senescence
Nucleic Acids Res.,
April 14, 2005;
33(7):
2192 - 2203.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|